Agile Therapeutics News

Agile Premium Finance Partners With EPayPolicy to Make Financing at Checkout Easier for Insurance Industry Clients

AUSTIN, Texas, May 14, 2024 /PRNewswire/ -- Agile Premium Finance, a division of First Financial Bank, has integrated new capabilities through its partnership with ePayPolicy to simplify premium fina

PR NewswireMay 14 07:31

Agile Therapeutics Releases Updated Investor Presentation

TipRanksApr 9 07:43

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 1 16:20

Agile Therapeutics' Balancing Act: Funding Challenges Threaten R&D and Twirla Rollout

TipRanksMar 30 01:01

Q4 2023 Agile Therapeutics Inc Earnings Call

Yahoo FinanceMar 28 22:34

Earnings Call Summary | Agile Therapeutics(AGRX.US) Q4 2023 Earnings Conference

The following is a summary of the Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript:Financial Performance:Agile Therapeutics reported a full year net revenue of $19.6 million in 2023, a

Futu NewsMar 28 10:10 · Conference Call

Agile Therapeutics Q4 Adj $(1.46) Misses $(0.92) Estimate, Sales $3.62M Miss $4.07M Estimate

Agile Therapeutics (NASDAQ:AGRX) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(0.92) by 58.7 percent. This is a 83.78 percent increase over losses of

BenzingaMar 28 07:17

Agile Therapeutics: Q4 Earnings Insights

Agile Therapeutics (OTC:AGRX) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM.Here's what investors need to know about the announcement.EarningsAgile Therapeutics missed estim

BenzingaMar 28 07:15

Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M

08:06 AM EDT, 03/28/2024 (MT Newswires) -- Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M

MT NewswiresMar 28 07:06

Press Release: Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand a

Dow JonesMar 28 07:06

Agile Therapeutics 4Q Loss $4.47M >AGRX

Agile Therapeutics 4Q Loss $4.47M >AGRX

Dow JonesMar 28 07:05

Agile Therapeutics 4Q Loss/Shr $1.51 >AGRX

Agile Therapeutics 4Q Loss/Shr $1.51 >AGRX

Dow JonesMar 28 07:05

Agile Therapeutics's Earnings: A Preview

Agile Therapeutics (NASDAQ:AGRX) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here's what investors need to know before the announcement.Analysts estimate that Agile Th

BenzingaMar 27 09:00

Why Agile Therapeutics (AGRX) Stock Is Down 60%

Agile Therapeutics Inc (OTC:AGRX) shares are trading lower by 61% to $0.24 during Tuesday's session after the company announced the suspension of its trading on the Nasdaq effective Tuesday. The compa

BenzingaMar 26 11:18

12 Health Care Stocks Moving In Monday's After-Market Session

GainersStoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. As per the news, the Q4 earnings re

BenzingaMar 25 16:32

Agile Therapeutics Announces Delisting From Nasdaq

PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that the Company has received a

GlobeNewswireMar 25 15:30

Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More

Seeking AlphaMar 24 07:01

Earnings Scheduled For March 22, 2024

Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. • 51 Talk Online Education (AMEX:COE) is proje

BenzingaMar 22 04:40

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before

GlobeNewswireMar 21 05:35

Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial results before

GlobeNewswireMar 20 07:15